Literature DB >> 6243521

Association of a lymphocyte purine enzyme deficiency (5'-nucleotidase) with combined immunodeficiency.

A Cohen, A Mansour, H M Dosch, E W Gelfand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6243521     DOI: 10.1016/0090-1229(80)90035-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  7 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).

Authors:  G de Saint-Basile; F Le Deist; J P de Villartay; N Cerf-Bensussan; O Journet; N Brousse; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts.

Authors:  G Mathioudakis; R A Good; Y Chernajovsky; N K Day; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?

Authors:  J N Stolk; A M Boerbooms; R A De Abreu; P J Kerstens; D G de Koning; R de Graaf; J Mulder; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

5.  Assignment of ecto-5'-nucleotidase to human chromosome 6.

Authors:  J M Boyle; Y Hey; A Guerts van Kessel; M Fox
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  Severe pulmonary vascular occlusive disease following bone marrow transplantation in Omenn syndrome.

Authors:  C Brückmann; W Lindner; R Roos; W Permanetter; R J Haas; S G Haworth; B H Belohradsky
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

7.  Augmentation of mixed lymphocyte response. Stimulatory activity by phorbol ester.

Authors:  J Okamura; M Letarte; E W Gelfand
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.